[{"AccountsPayableCurrent_0_Q3_USD":23660000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3869000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-1268000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-163000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-262000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":13000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-1006000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-176000.0,"OtherAssetsNoncurrent_0_Q3_USD":1844000.0,"OtherAssetsCurrent_0_Q3_USD":20731000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":19966000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":119714000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":128718000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-5677000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":17740000.0,"OperatingIncomeLoss_1_Q3_USD":-113596000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NonoperatingIncomeExpense_3_Q3_USD":-44438000.0,"NonoperatingIncomeExpense_1_Q3_USD":-15998000.0,"NetIncomeLoss_3_Q3_USD":-378192000.0,"NetIncomeLoss_1_Q3_USD":-129706000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-261122000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":82580000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":33686000.0,"LiabilitiesFairValueAdjustment_3_Q3_USD":-7640000.0,"LiabilitiesFairValueAdjustment_1_Q3_USD":-3328000.0,"LiabilitiesCurrent_0_Q3_USD":139969000.0,"OperatingIncomeLoss_3_Q3_USD":-333193000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":131000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":2388000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":816049000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":182736000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":184110000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1777000.0,"StockholdersEquity_0_Q3_USD":801540000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":9.72,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":9.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3_Q3_shares":674000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1_Q3_shares":397000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1057000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":76898000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":24921000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2687350000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":11497000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":300655000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":103738000.0,"RepaymentsOfSeniorDebt_3_Q3_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":58830000.0,"ProfitLoss_3_Q3_USD":-378192000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":5035000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":902687000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":31436000.0,"ProceedsFromDerivativeInstrumentFinancingActivities_3_Q3_USD":2250000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":9093000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1277243000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":184110000.0,"Liabilities_0_Q3_USD":475703000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":1744000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":58700000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q3_USD":19400000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-379460000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-129869000.0,"CommonStockValue_0_Q3_USD":18000.0,"CommonStockSharesOutstanding_0_Q3_shares":184554000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-144938000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":54017000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":54017000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":5311000.0,"Cash_0_Q3_USD":5681000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":867063000.0,"AssetsCurrent_0_Q3_USD":986135000.0,"Assets_0_Q3_USD":1277243000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":18454000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":17634000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":72269000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":24657000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":24657000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":3492435000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-3563000.0,"AccountsReceivableNetCurrent_0_Q3_USD":28994000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":34219000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":18734000.0,"CostsAndExpenses_1_Q3_USD":138517000.0,"CostsAndExpenses_3_Q3_USD":410091000.0,"InventoryNet_0_Q3_USD":15330000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":4198000.0,"InterestPaidNet_3_Q3_USD":0.0,"InterestExpense_3_Q3_USD":0.0,"InterestExpense_1_Q3_USD":0.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-814000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":-3837000.0,"IncreaseDecreaseInInventories_3_Q3_USD":38000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":18350000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-605000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-9895000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1247000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":561000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":112000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-377631000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-129594000.0,"Goodwill_0_Q3_USD":76501000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":90702000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":29468000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":32882000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-82000.0,"EarningsPerShareDiluted_3_Q3_USD":-2.07,"EarningsPerShareDiluted_1_Q3_USD":-0.7,"EarningsPerShareBasic_3_Q3_USD":-2.07,"EarningsPerShareBasic_1_Q3_USD":-0.7,"DerivativeLiabilitiesNoncurrent_0_Q3_USD":21387000.0,"DepreciationAndAmortization_3_Q3_USD":10710000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":9388000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":182736000.0,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]